Home > Specialists > Urology > Dr. Jin Zhang (张进)
Specialty & Clinical Focus:
Shanghai-based urologist and kidney cancer specialist at Renji Hospital, Shanghai Jiao Tong University School of Medicine, with a clinical focus on kidney tumors, kidney cancer surgery, advanced kidney cancer, von Hippel–Lindau (VHL) disease, and hereditary leiomyomatosis and renal cell carcinoma (HLRCC).
Professional Title & Qualifications:
Chief Physician
M.D.
Master's Supervisor
Hospital & Department：
Shanghai Renji Hospital, Jiao Tong University – Department of Urology
(address: No. 160 Pujian Road, Pudong New Area, Shanghai, 200127)
Dr. Jin Zhang (张进) - Urologist
Personal Biography
Dr. Jin Zhang is a Chief Physician, M.D., and Master's Supervisor in the Department of Urology at Renji Hospital, Shanghai Jiao Tong University School of Medicine. With more than 20 years of experience in kidney cancer surgery, clinical care, and translational research, he leads Renji Hospital's multidisciplinary team for VHL disease and HLRCC. He performs kidney-tumor surgery for more than 200 patients each year.
Why Choose Dr. Jin Zhang for Urological Care?
Dr. Jin Zhang is a Chief Physician and Master's Supervisor in the Department of Urology at Renji Hospital, Shanghai Jiao Tong University School of Medicine. With more than 20 years of clinical and research experience in kidney cancer, he leads Renji Hospital's multidisciplinary team for VHL disease and HLRCC and performs kidney-tumor surgery for more than 200 patients annually. His integration of high-volume clinical practice with translational research has also been recognized through national and Shanghai medical science awards.
For international patients considering a remote specialist review before traveling to Shanghai, Dr. Zhang's focused experience is particularly relevant to kidney tumors, advanced kidney cancer, VHL disease, and HLRCC. His clinical scope includes laparoscopic and Da Vinci robotic-assisted kidney-sparing procedures, together with multidisciplinary management involving surgery, targeted therapy, or immunotherapy when clinically indicated. Preparing imaging, pathology reports, prior treatment records, and a focused question list can help him provide a case-specific opinion on potential next steps.
Pre-Travel Case Review & Specialist Liaison
For international patients considering treatment in Shanghai, a pre-travel specialist review can help clarify the case before flights and hospital arrangements are made. MedBridgeNZ coordinates client-authorized medical-record preparation, translation where required, secure document transfer, and appointment communication with Dr. Zhang's team at Renji Hospital. Dr. Zhang will review the submitted records, address the patient's stated questions, and provide his specialist opinion and recommendations on potential clinical pathways.
If the patient decides to pursue in-person care in China, MedBridgeNZ can coordinate hospital appointment requests, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative support. These services help the patient organize the practical steps around the hospital-confirmed pathway before travel.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Jin Zhang
Areas of Expertise
Kidney tumors (clinical and basic research)
Surgical treatment for kidney cancer
Comprehensive treatment of advanced kidney cancer
von Hippel-Lindau (VHL) disease
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
13,500 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Chief Physician, Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine
Over 20 years of experience in clinical practice, research, and patient care in urology, specializing in kidney cancer.
Education & Training
Awards & Honors
Science and Technology Progress Award, Ministry of Education, P.R.C. (2016)
First Prize, Shanghai Medical Science and Technology Progress Award (Second Completer)
First Prize, Ministry of Education Science and Technology Award (Second Completer)
Academic & Professional Memberships
Member, Oncology Panel, Chinese Urological Association (Shanghai Branch)
Member, Expert Committee on Urothelial Carcinoma, Chinese Society of Clinical Oncology (CSCO)
Member, Chinese TSC-AML Collaboration Group
Member, Kidney Cancer Group, Chinese Anti-Cancer Association Genitourinary Cancer Professional Committee
Member, International Kidney Cancer Coalition (IKCC)
Research & Publications
Selected Peer-Reviewed Publications
Xu Y et al. Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma. Eur Urol. 2023;83(2):163–172. PMID: 35715365
Huang J et al. Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial. J Immunother Cancer. 2024;12(6):e008475. PMID: 38862251
Zhang J et al. Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families. J Cancer Res Clin Oncol. 2008;134(11):1211–1218. PMID: 18446368
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Can Dr. Jin Zhang review my kidney cancer case before I travel to China?
Dr. Zhang's clinical focus includes kidney tumors, kidney cancer surgery, advanced kidney cancer, VHL disease, and HLRCC. Through a coordinated pre-travel review, Dr. Zhang will review the submitted records, respond to the patient's stated questions, and provide his specialist opinion and recommendations. This can help the patient understand whether the case falls within his clinical focus and what further evaluation or treatment pathways may be discussed before deciding whether to travel to Shanghai.
How can I request a remote specialist review or appointment with Dr. Zhang from overseas?
Contact MedBridgeNZ to request remote specialist-review coordination or an in-person appointment request with Dr. Zhang. With your authorization, our team coordinates medical-record preparation, translation where required, secure document transfer, and appointment communication with Dr. Zhang's team at Renji Hospital. Once the hospital confirms the relevant arrangement, we provide the practical scheduling details and, for patients traveling to China, can also coordinate medical invitation or visa-document support and related travel logistics.
What medical records should I prepare for Dr. Zhang's review?
For a useful review, prepare your diagnostic imaging and imaging reports, pathology or biopsy reports where available, previous operation or treatment records, and a concise list of the questions you want Dr. Zhang to address. MedBridgeNZ can help organize the file set, identify documents requiring translation, and transfer the records with your authorization. Clear, chronological records make it easier for the specialist to understand the case history and provide a focused response.
How does MedBridgeNZ support communication and medical travel to Renji Hospital?
MedBridgeNZ coordinates translation and non-clinical bilingual administrative support for remote reviews and hospital visits in Shanghai. We help relay appointment information, organize translated documents, and support communication between the patient and the hospital team without replacing the specialist's medical explanation. For an in-person pathway, we can also assist with hospital appointment requests, medical invitation or visa-document coordination, travel planning, and practical navigation at Renji Hospital.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative support before and during travel. We do not provide medical advice, diagnosis, or treatment. Hospital, specialist, diagnostic, treatment, and travel costs remain separate from MedBridgeNZ coordination fees unless expressly stated otherwise in writing.